Impaired BCRP function in the kidney reduces tubular uric acid excretion, while decreased BCRP activity in the intestine and liver diminishes extra-renal uric acid clearance and increases renal uric acid load, collectively promoting the development of hyperuricemia. Here, ABCG2 is linked to hyperuricemia.